PAUL BALDWIN

Support of federal auditing standards for downstream contractors of Medicare drug benefit sponsors (no legislation introduced).

Drug Enforcement Administration proposed rule on disposal of controlled substances in long term care facilities.

Issues related to operation of Medicare Part D in new plan year

Support of HR 4215: Fair audit standards for pharmacy providers in Medicare Part D

HR 4215: Support legislation relating to standardized audit standards for pharmacies with Medicare drug benefit sponsors

Antipsychotic drug use in nursing homes

Rulemaking with respect to Medicaid Federal Upper Limits

Implementation of provisions of Affordable Care Act related to reduced quanitity dispensing under Medicare Part D and proposed rule from CMS related to independence of consultant pharmacists in nursing homes.

Advocacy concerning a proposed rule related to Medicare Part D long term care pharmacy. Advocacy concerning amendments to S1699

Advocacy in support of S1560 promoting changes to Controlled Substances Act providing access to pain medication for nursing home residents.

Encouraging consideration of SB 1560; related to ensuring access to pain medication to nursing home residents.

Modification of proposed rule implementing Section 3310 of Affordable Care Act

Modify Drug Enforcement Administration policy on dispensing of controlled substances to residents of nursing homes.

Federal Regulations implementing Section 3310 of the Patient Protection and Affordable Care Act

Revision of provisions of the Controlled Substances Act as relating to provision of controlled substances to residents of skilled nursing facilities

Modification of Section 3310 of Affordable Care Act

Implementation of Section 3310 of Affordable Care Act of 2010, related to regulations implementing requirement for short-cycle dispensing in long-term care facilities.

DEA policies regarding dispensing of controlled substances to residents of long-term care facilities.

Implementation of Patient Protection and Affordable Care Act

Issues related to controlled substances distribution and accountability in skilled nursing facilities

HR3590: Improved access under Medicare Part D for long-term care residents

HR3590: Advocate for long-term care resident protections under Medicare Part D HR 3962: Advocate for long-term care resident protections under Medicare Part D

Improve protections to Medicare Part D beneficiaries in long-term care settings.

Promote improvements to health reform legislation for access to medications for institutionalized individuals under the Medicare Part D program.

Improvement in medication access for long-term care residents under the Medicare drug benefit.

Improvement of access to medications for residents of long-term care facilities under the Medicare drug benefit

Seeking clarifying information from Drug Enforcement Administration on emergency oral prescription policy

Improvements to Medicare Prescription Drug Program for Long-Term Care Residents

Advocate for co-sponsorship of HR 4541: Medicare Part D Long-Term Care Patient Protection Act Advocate for improvements to Medicare drug benefit for long-term care residents

Advocate for co-sponsorship of HR 4541: Medicare Part D Long-Term Care Patient Protection Act Advocate for improvements to Medicare drug benefit for long-term care residents.

General improvements in Medicare Part D for long-term care residents. Advocacy in support of HR 4541

Improvement of the Medicare Drug Benefit for long-term care residents. Advocacy related to support of HR 4541